G747-0039 Screening compound: 1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-1,2-dihydropyridin-2-one

G747-0039 Screening compound: 1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-1,2-dihydropyridin-2-one
G747-0039 Screening compound: 1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-1,2-dihydropyridin-2-one alternative view

Chemical Structure Depiction of ChemDiv screening compound G747-0039
1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-1,2-dihydropyridin-2-one

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G747-0039

Molecular Formula

C29H29FN4O2 (C29 H29 FN4 O2)

Compound Name

1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-1,2-dihydropyridin-2-one

IUPAC name

1-benzyl-3-[(3-fluorophenyl)[4-(pyridin-2-yl)piperazin-1-yl]methyl]-4-hydroxy-6-methyl-12-dihydropyridin-2-one

SMILES

CC(N1Cc2ccccc2)=CC(O)=C(C(c2cccc(F)c2)N(CC2)CCN2c2ncccc2)C1=O

InChI

InChI=1S/C29H29FN4O2/c1-21-18-25(35)27(29(36)34(21)20-22-8-3-2-4-9-22)28(23-10-7-11-24(30)19-23)33-16-14-32(15-17-33)26-12-5-6-13-31-26/h2-13,18-19,28,35H,14-17,20H2,1H3/t28-/m0/s1

InChI Key

TUIUDGLBGZPRJP-NDEPHWFRSA-N

MDL Number (MFCD)

MFCD09237433

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

484.57

Hydrogen Bond Acceptors Count

5.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

6.00

Number of Nitrogen and Oxygen Atoms

6

Partition Coefficient, logP

4.984

Distribution Coefficient, logD

3.076

Water Solubility, LogSw

-4.52

Polar Surface Area

45.130

Acid Dissociation Constant (pKa)

5.50

Base Dissociation Constant (pKb)

6.09

Number of Chiral Centers

1.00

Percent sp3 carbon bonding

24.10

G747-0039 in Drug Discovery

Included in Screening Libraries

3D-Pharmacophore Based Diversity Library (49813 compounds)

CNS Targets (44014 compounds)

MCL1 Targeted Library (12200 compounds)

SmartTM Library (51161 compounds)

Anti-HIV1 Library (19540 compounds)

Epigenetics Focused Set (26518 compounds)

Peptidomimetic Library (37031 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Nervous system
  • Digestive system
  • Respiratory tract
  • Male
  • Female
  • Hemic and lymphatic
  • Antiviral
  • Infections
  • Immune system
Mechanism of action:
  • PPI modulators
Structure:
  • Mimetics

References: we are preparing a list of scientific research reports with G747-0039 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G747-0039?
Check Price and Availability of G747-0039, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G747-0039 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G747-0039
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G747-0039
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G747-0039 available by request